Real-World Comparison of Effectiveness, Treatment Persistence, and Safety of First-Line Advanced Therapies at 1 Year for Ulcerative Proctitis

被引：0
|
作者：
Dalal, Rahul S. [1 ]
Clarke, Lindsay M. [1 ]
Carlin, Alex [1 ]
Cabral, Heidy [1 ]
Allegretti, Jessica R. [1 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Gastroenterol Hepatol & Endoscopy, Boston, MA USA
来源：
INFLAMMATORY BOWEL DISEASES | 2024年
关键词：
ulcerative colitis; inflammatory bowel disease; biologics; bio-na & iuml; ve; INFLAMMATORY-BOWEL-DISEASE;
D O I：
10.1093/ibd/izae215
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
In this retrospective cohort study, vedolizumab was associated with higher odds of steroid-free clinical remission at 1 year compared to anti-TNF agents for bio-na & iuml;ve patients with ulcerative proctitis.
引用
收藏
页码：1174 / 1177
页数：4
相关论文
共 50 条
  • [21] An Analysis of the Effectiveness and Safety of Upadacitinib in the Treatment of Inflammatory Bowel Disease: A Multicenter Real-World Study
    Wu, Hongzhen
    Xie, Tingting
    Yu, Qiao
    Su, Tao
    Zhang, Min
    Wu, Luying
    Wang, Xiaoling
    Peng, Xiang
    Zhi, Min
    Yao, Jiayin
    BIOMEDICINES, 2025, 13 (01)
  • [22] Effectiveness of biologic therapies in achieving treatment targets in inflammatory bowel disease; real-world data from the Middle East (ENROLL study)
    Shehab, Mohammad
    Alfadhli, Ahmad
    Abdullah, Israa
    Alostad, Wrood
    Marei, Alaa
    Alrashed, Fatema
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [23] Meta-analysis: Real-world effectiveness and safety of ustekinumab in patients with ulcerative colitis
    Taxonera, Carlos
    Olivares, David
    Lopez-Garcia, Olga N.
    Alba, Cristina
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (06) : 610 - 619
  • [24] Comparison of the Effectiveness of Vedolizumab and Ustekinumab in Patients with Ulcerative Colitis: A Real-World Retrospective Study
    Nomura, Kei
    Shibuya, Tomoyoshi
    Odakura, Rina
    Haraikawa, Mayuko
    Ishino, Hirotaka
    Orikasa, Masayuki
    Omori, Masashi
    Koma, Masao
    Ito, Kentaro
    Maruyama, Takafumi
    Nomura, Osamu
    Ishikawa, Dai
    Hojo, Mariko
    Nagahara, Akihito
    BIOMEDICINES, 2024, 12 (09)
  • [25] Switching within versus out of class following first-line TNFi failure in ulcerative colitis: real-world outcomes from a German claims data analysis
    Zhuleku, Evi
    Wirth, Daniel
    Nissinen, Riikka
    Bravata, Ivana
    Ziavra, Despina
    Duva, Andreas
    Lee, Jennifer
    Fuchs, Andreas
    Mueller, Sabrina
    Wilke, Thomas
    Bokemeyer, Bernd
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2024, 17
  • [26] Real World Clinical Effectiveness and Safety of Ozanimod in the Treatment of Ulcerative Colitis: 1-Year Follow-Up from a Tertiary Center
    Nathaniel A. Cohen
    David Choi
    Nicole Garcia
    Natalie K. Choi
    Emma Picker
    Noa Krugliak Cleveland
    Russell D. Cohen
    Sushila R. Dalal
    Joel Pekow
    David T. Rubin
    Digestive Diseases and Sciences, 2024, 69 : 579 - 587
  • [27] Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort study
    Amiot, Aurelien
    Filippi, Jerome
    Abitbol, Vered
    Cadiot, Guillaume
    Laharie, David
    Serrero, Melanie
    Altwegg, Romain
    Bouhnik, Yoram
    Peyrin-Biroulet, Laurent
    Gilletta, Cyrielle
    Roblin, Xavier
    de Chambrun, Guillaume Pineton
    Vuitton, Lucine
    Bourrier, Anne
    Nancey, Stephane
    Gornet, Jean-Marc
    Nahon, Stephane
    Bouguen, Guillaume
    Viennot, Stephanie
    Pariente, Benjamin
    Fumery, Mathurin
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (11) : 1039 - 1046
  • [28] Real-world assessment of effectiveness and safety of filgotinib in 286 patients with ulcerative colitis in 9 UK centres
    Young, David
    Rahmany, Sohail
    Taylor, Deborah
    Davis, Emma
    Colwill, Michael
    Mehta, Sonia Kalyanji
    Campbell, Roisin
    Hazel, Karl
    Sethi-Arora, Karishma
    Ritchie, Susan
    Heinson, Ashley, I
    Moyses, Helen
    Bodger, Keith
    Johnston, Emma
    Hicks, Lucy
    Dhar, Anjan
    Limdi, Jimmy
    Cooney, Rachel
    Seenan, John Paul
    Patel, Kamal
    Walsh, Alissa
    Cummings, Fraser
    DRUGS IN CONTEXT, 2025, 14
  • [29] Real-World Effectiveness and Safety of Tofacitinib in Patients With Ulcerative Colitis: Systematic Review With Meta-Analysis
    Taxonera, Carlos
    Olivares, David
    Alba, Cristina
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (01) : 32 - 40
  • [30] Real-world clinical effectiveness and safety of vedolizumab and anti-tumor necrosis factor alpha treatment in ulcerative colitis and Crohn's disease patients: a German retrospective chart review
    Helwig, Ulf
    Mross, Michael
    Schubert, Stefan
    Hartmann, Heinz
    Brandes, Alina
    Stein, Dara
    Kempf, Christian
    Knop, Jana
    Campbell-Hill, Sarah
    Ehehalt, Robert
    BMC GASTROENTEROLOGY, 2020, 20 (01)
12345